XML 103 R32.htm IDEA: XBRL DOCUMENT v2.4.0.6
Share-Based Compensation
12 Months Ended
Dec. 31, 2010
Dec. 31, 2009
Ergotron, Inc
Dec. 31, 2008
Ergotron, Inc
SHARE-BASED COMPENSATION
 
9.   SHARE-BASED COMPENSATION
 
Incentive Compensation Plan
 
On December 17, 2009, the Company established the 2009 Omnibus Incentive Plan (the “Incentive Plan”) which allows for grants of options, stock appreciation rights, restricted stock, other stock-based awards and performance-based compensation awards. The Incentive Plan is administered by the Board of Directors, the Compensation Committee of the Board of Directors, or any other committee designated by the Board of Directors to administer the Incentive Plan (the “Committee”). Participants consist of such employees, directors and other individuals providing services to the Company, or any subsidiary or affiliate, as the Committee in its sole discretion determines and whom the Committee may designate from time to time to receive awards.
 
Under the 2009 Plan, 2,153,110 shares were authorized for grant through December 17, 2019, of which 1,076,555 may be in the form of incentive stock options. The maximum number of shares for which options and stock appreciation rights may be granted to any participant in any calendar year is 627,990, and the maximum number of shares with respect to other awards denominated in shares in any calendar year is 627,990. The maximum value of cash payable with respect to awards denominated in cash or property that may be granted to any participant in any plan year is $5.0 million, subject to certain adjustments as defined. In the event that any outstanding award expires, is forfeited, cancelled or otherwise terminated without the issuance of shares or is otherwise settled for cash, the shares subject to such award shall again be available for awards. At December 31, 2010, there are 671,148 remaining shares available for grant under the Incentive Plan.
 
Stock Options
 
Options granted under the Plan generally vest at the rate of 20% on each anniversary of the grant date, beginning with the first anniversary of the grant date, with 100% vesting upon the fifth anniversary of the grant date, and, unless terminated earlier, expire on the tenth anniversary of the grant date.
 
The following table summarizes the Successor’s common stock option transactions for the years ended December 31:
 
                                 
    2010     2009  
          Weighted
          Weighted
 
          Average
          Average
 
    Number of
    Exercise
    Number of
    Exercise
 
    Shares     Price     Shares     Price  
 
Outstanding, Beginning of Year
    710,731     $ 17.50           $  
Granted
    92,000       22.61       710,731       17.50  
Exercised
                       
Forfeited
    (21,750 )     17.50              
                                 
Outstanding, End of Year
    780,981     $ 18.10       710,731     $ 17.50  
                                 
 
The weighted average grant date fair value of options granted was approximately $8.05 and $4.66 during the years ended December 31, 2010 and 2009, respectively. There were no options granted during 2008.
 
The estimated fair value of the options granted was measured on the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions:
 
         
    December 31,
    2010   2009
 
Risk-Free Interest Rate
  2.39%   2.19%
Expected Term
  5.78 years   5.78 years
Expected Volatility
  55.0%   55.0%
Expected Dividend Yield
  —%   —%
 
The risk-free interest rate for periods within the life of the option is based upon a blend of U.S. Treasury bond rates with maturities equal to the expected term of the options. The expected term assumption was derived using a binomial model analysis. The expected volatility assumption is based upon the historical volatility of comparable public companies’ stock as well as the implied volatility of outstanding options for the comparable companies that had such options. The dividend yield represents the expected dividends on the Company’s common stock for the expected term of the option.
 
At December 31, 2010, there were 139,796 vested and exercisable options outstanding with a weighted average exercise price of $17.50, aggregate intrinsic value of approximately $2.6 million, and weighted average remaining contractual term of approximately 8.9 years. The aggregate fair value of options vesting during the year ended December 31, 2010 was approximately $0.7 million. No options were exercised during the three years ended December 31, 2010. Additionally, at December 31, 2010, 582,662 additional options were expected to vest with a weighted average exercise price of approximately $18.23, and a weighted average remaining term of approximately 9.0 years. The aggregate intrinsic value of these options was approximately $10.4 million. The aggregate intrinsic value of options represents the total pre-tax intrinsic value (the difference between the estimated fair value of the Company’s stock on December 31, 2010 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on December 31, 2010. This amount changes based upon the fair market value of the Successor’s common stock.
 
As of December 31, 2010, there was approximately $3.1 million of unrecognized compensation cost related to stock options granted under the Incentive Plan. That cost is expected to be recognized on a straight-line basis over a weighted average period of approximately 4.0 years. Total compensation expense related to stock options was approximately $0.8 million for the year ended December 31, 2010. The related tax benefit recognized for the year ended December 31, 2010 totaled approximately $0.3 million. No compensation cost was recognized during the 2009 Successor Period for stock options.
 
Restricted Stock
 
The Company has awarded restricted shares of common stock to certain key employees. These shares are eligible to become vested in annual installments beginning in 2010 based upon the achievement of specified levels of Adjusted EBITDA, as defined, for each of the years ended December 31, 2010, 2011, 2012 and 2013. The shares, if any, are vested as of December 31 of each year. However, as the number of shares vesting is contingent upon the Company’s financial results, determined based upon the issuance of audited financial statements, the actual vesting of shares does not occur until the first quarter of the following year.
 
Restricted stock has the same cash dividend and voting rights as other common stock and, once issued, is considered to be legally issued and outstanding (even when unvested). Recipients of restricted stock are entitled to receive dividends when and if the Successor pays a cash dividend on its common stock. Such dividends are payable only upon the vesting of the related restricted shares.
 
The following table summarizes the Successor’s restricted stock activity for the years ended December 31:
 
                                 
    2010     2009  
          Weighted Average
          Weighted Average
 
    Number of
    Grant Date
    Number of
    Grant Date
 
    Shares     Fair Value     Shares     Fair Value  
 
Unvested, Beginning of Year
    710,731     $ 11.29           $  
Granted
    2,000       10.85       710,731       11.29  
Vested
    (175,261 )     11.29              
Forfeited
    (11,750 )     11.29              
                                 
Unvested, End of Year
    525,720     $ 11.29       710,731     $ 11.29  
                                 
 
The cost of these restricted stock awards, calculated as the estimated fair market value of the shares on the date of grant, net of estimated forfeitures, is being recognized as it becomes probable that the restricted shares, or any portion thereof, will vest. The fair value of the 2010 grants is based upon the closing price of the Company’s stock on the date of grant. The fair value of the 2009 grants was estimated using a combination of the income and market approaches. Total compensation expense recognized in 2010 related to restricted stock was approximately $2.0 million. The related tax benefit recognized for the year ended December 31, 2010 totaled approximately $0.8 million. No compensation cost was recognized during the 2009 Successor Period for restricted stock awards. At December 31, 2010 there was approximately $5.5 million of unrecognized compensation cost with respect to restricted stock granted under the Incentive Plan.
 
The targeted Adjusted EBITDA for 2013 has not been established. Therefore, under ASC 505-50, “Equity-Based Payments to Non-Employees”, a measurement date has not occurred for accounting purposes with respect to the shares expected to vest in that year.
 
Predecessor Stock-Based Compensation
 
At December 31, 2008, certain employees and consultants held approximately 23,269 C-1 units and approximately 40,745 C-2 units, which represented equity interests in THL-Nortek Investors, LLC (“Investors LLC”), the parent of NTK Holdings, that functioned similar to stock awards. The C-1 units vested pro rata on a quarterly basis over a three-year period and approximately 23,116 were vested at December 31, 2008. The total fair value of the C-1 units was approximately $1.2 million and approximately $0.1 million remained to be amortized at December 31, 2008. The C-2 units only vested in the event that certain performance-based criteria, as defined, were met. At December 31, 2008, there was approximately $1.6 million of unamortized stock-based employee compensation with respect to the C-2 units, which would have been recognized in the event that it became probable that the C-2 units or any portion thereof would vest. The C-1 and C-2 units were valued using the Black-Scholes option pricing model to determine the freely-traded call option value based upon information from comparable public companies, which was then adjusted to reflect the discount period, the minority interest factor and the lack of marketability factor to arrive at the final valuations.
 
The Predecessor recorded stock-based compensation charges in selling, general and administrative expense, net of approximately $0.1 million for the 2009 Predecessor Period and $0.1 million for the year ended December 31, 2008. These units were cancelled in connection with the Reorganization.
 
NOTE J — STOCK-BASED COMPENSATION
 
The Company’s 1997 Incentive Stock Option Plan (the “1997 Plan”) provided for the granting of options to both employees and non-employees for the purchase of up to 3,307,642 shares of the Company’s Class A common stock. The 1997 Plan expired in December 2007 and no further options may be granted thereunder. During 2008, the Board of Directors approved the 2008 Incentive Stock Option Plan (the “2008 Plan”) and authorized 500,000 shares for grant under the plan. There were 27,720 shares available for future grant under the 2008 Plan as of December 31, 2009. The 2008 Plan expires in 2018 at which time no further options may be granted under the Plan. Under both plans, the terms of options granted are determined by the Board of Directors, but in no event shall the exercise period exceed ten years from the date of grant. The exercise price is established by the terms of the individual plan agreements and is equal to the fair market value of the stock at the date of grant, as determined by the Board of Directors. Options issued become exercisable over vesting periods ranging from zero to five years as provided in the individual plan agreements. Upon a change in control of the Company, as defined in the Plans, all options outstanding on the date of the change in control become fully exercisable.
 
Total stock-based compensation for options granted to employees included in operating expense was $188,588 in 2009. As of December 31, 2009, approximately $87,400 of total unrecognized compensation costs related to non-vested awards is expected to be recognized over a weighted-average period of approximately one year.
 
The fair value of each stock option award was estimated on the date of grant using the Black-Scholes option pricing model in 2009. The following assumptions were used to estimate the fair value of options:
 
         
Assumptions:   2009
 
Expected dividend yield
    0%  
Expected life
    1 year  
Expected volatility
    30%  
Risk-free interest rate
    0.33% to 0.66%  
 
The weighted-average fair value of options granted during the year ended December 31, 2009 was $0.25.
 
A summary of activity related to common stock options is as follows for the year ended December 31, 2009:
 
                 
          Weighted-
 
    Number of
    Average
 
    Common Stock
    Exercise
 
    Options     Price  
 
Options outstanding at December 31, 2008
    2,966,180     $ 4.49  
Granted
    289,800       6.72  
Canceled
    (107,255 )     4.55  
Exercised
    (1,831,424 )     2.50  
                 
Options outstanding at December 31, 2009
    1,317,301     $ 4.95  
                 
Options exercisable at December 31, 2009
    976,626     $ 4.76  
                 
 
Information regarding weighted-average exercise prices, number of options outstanding, and number of options exercisable as of December 31, 2009, under the stock option plan is as follows:
 
                                 
    Options outstanding     Options exercisable  
Range of
        Weighted-average
          Weighted-average
 
exercise prices   Number     exercise price     Number     exercise price  
 
$0.46 – $2.52
    1,000     $ 2.52       1,000     $ 2.52  
$3.00 – $3.70
    120,750     $ 3.11       120,750     $ 3.11  
$4.23 – $5.50
    917,241     $ 4.84       768,756     $ 4.83  
$5.76 – $6.35
    188,270     $ 5.78       26,920     $ 5.78  
$6.47 – $8.24
    90,040     $ 6.73       59,200     $ 6.71  
                                 
      1,317,301     $ 4.95       976,626     $ 4.76  
                                 
 
NOTE K — STOCK-BASED COMPENSATION
 
The Company’s 1997 Incentive Stock Option Plan (the “1997 Plan”) provided for the granting of options to both employees and non-employees for the purchase of up to 3,307,642 shares of the Company’s Class A common stock. The 1997 Plan expired in December 2007 and no further options may be granted thereunder. During 2008, the Board of Directors approved the 2008 Incentive Stock Option Plan (the “2008 Plan”) and authorized 500,000 shares for grant under the plan. There were 316,180 shares available for future grant under the 2008 Plan as of December 31, 2008. The 2008 Plan expires in 2018 at which time no further options may be granted under the Plan. Under both plans, the terms of options granted are determined by the Board of Directors, but in no event shall the exercise period exceed ten years from the date of grant. The exercise price is established by the terms of the individual plan agreements and is equal to the fair market value of the stock at the date of grant, as determined by the Board of Directors. Options issued become exercisable over vesting periods ranging from zero to five years as provided in the individual plan agreements. Upon a change in control of the Company, as defined in the Plans, all options outstanding on the date of the change in control become fully exercisable.
 
Total stock-based compensation for options granted to employees included in operating expense was $153,636 in 2008 and $84,018 in 2007. As of December 31, 2008, approximately $168,000 of total unrecognized compensation costs related to non-vested awards is expected to be recognized over a weighted-average period of approximately two years.
 
Prior to the Company’s adoption of SFAS 123R on January 1, 2006, the Company granted 37,190 options to outside parties during fiscal year 2005 which remain outstanding at December 31, 2008. The Company records compensation expense based on the fair value of these options within operating expenses upon the vesting of the optioned shares. During fiscal years 2008 and 2007, the Company recorded compensation expense of $13,138 and $13,144. As of December 31, 2008 these options have been fully expensed and no further compensation expense will be recognized in future years.
 
The fair value of each stock option award was estimated on the date of grant using the Black-Scholes option pricing model in 2008 and 2007. The following assumptions were used to estimate the fair value of options:
 
                 
Assumptions:   2008   2007
 
Expected dividend yield
    0%       0%  
Expected life
    2 years       3 years  
Expected volatility
    30%       30%  
Risk-free interest rate
    1.5% to 2.5%       3.9% to 4.8%  
 
The weighted-average fair value of options granted during the years ended December 31, 2008 and 2007 were $1.07 and $1.75, respectively.
 
A summary of activity related to common stock options is as follows for the years ended December 31:
 
                 
          Weighted-
 
    Number of
    Average
 
    Common Stock
    Exercise
 
    Options     Price  
 
Outstanding at December 31, 2006
    3,115,721     $ 4.29  
Granted
    67,608       5.54  
Canceled
    (93,880 )     4.24  
Exercised
    (177,835 )     3.06  
                 
Outstanding at December 31, 2007
    2,911,614       4.39  
Granted
    186,860       5.79  
Canceled
    (102,615 )     4.72  
Exercised
    (29,679 )     2.82  
                 
Options outstanding at December 31, 2008
    2,966,180       4.49  
                 
 
Information regarding weighted-average exercise prices, number of options outstanding, and number of options exercisable as of December 31, 2008, under the stock option plan is as follows:
 
                                     
      Options outstanding     Options exercisable  
Range of
          Weighted-average
          Weighted-average
 
exercise prices     Number     exercise price     Number     exercise price  
 
$ 0.46-$2.52       227,474     $ 1.80       227,474     $ 1.80  
$ 3.00-$3.70       302,300     $ 3.07       297,900     $ 3.07  
$ 4.23-$5.50       2,223,046     $ 4.83       1,660,028     $ 4.82  
$ 5.76-$6.35       213,360     $ 5.78       7,456     $ 5.76  
                                     
          2,966,180     $ 4.49       2,192,858     $ 4.27